1. Home
  2. PHAR vs NPKI Comparison

PHAR vs NPKI Comparison

Compare PHAR & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • NPKI
  • Stock Information
  • Founded
  • PHAR 1988
  • NPKI 1932
  • Country
  • PHAR Netherlands
  • NPKI United States
  • Employees
  • PHAR N/A
  • NPKI N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • NPKI Metal Fabrications
  • Sector
  • PHAR Health Care
  • NPKI Industrials
  • Exchange
  • PHAR Nasdaq
  • NPKI Nasdaq
  • Market Cap
  • PHAR 679.0M
  • NPKI 665.2M
  • IPO Year
  • PHAR N/A
  • NPKI N/A
  • Fundamental
  • Price
  • PHAR $9.29
  • NPKI $7.62
  • Analyst Decision
  • PHAR Strong Buy
  • NPKI
  • Analyst Count
  • PHAR 3
  • NPKI 0
  • Target Price
  • PHAR $27.00
  • NPKI N/A
  • AVG Volume (30 Days)
  • PHAR 6.7K
  • NPKI 443.4K
  • Earning Date
  • PHAR 03-13-2025
  • NPKI 02-19-2025
  • Dividend Yield
  • PHAR N/A
  • NPKI N/A
  • EPS Growth
  • PHAR N/A
  • NPKI N/A
  • EPS
  • PHAR N/A
  • NPKI N/A
  • Revenue
  • PHAR $285,745,000.00
  • NPKI $748,372,000.00
  • Revenue This Year
  • PHAR $20.08
  • NPKI N/A
  • Revenue Next Year
  • PHAR $9.22
  • NPKI N/A
  • P/E Ratio
  • PHAR N/A
  • NPKI $19.48
  • Revenue Growth
  • PHAR 30.64
  • NPKI 93.70
  • 52 Week Low
  • PHAR $6.65
  • NPKI $5.61
  • 52 Week High
  • PHAR $13.20
  • NPKI $8.65
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 48.44
  • NPKI N/A
  • Support Level
  • PHAR $9.37
  • NPKI N/A
  • Resistance Level
  • PHAR $10.01
  • NPKI N/A
  • Average True Range (ATR)
  • PHAR 0.55
  • NPKI 0.00
  • MACD
  • PHAR -0.13
  • NPKI 0.00
  • Stochastic Oscillator
  • PHAR 13.82
  • NPKI 0.00

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About NPKI NPK International Inc. Common Stock

NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.

Share on Social Networks: